Synlogic Inc (NASDAQ:SYBX) Stock Is Shorted More

September 30, 2018 - By Jack Shaw

The stock of Synlogic Inc (NASDAQ:SYBX) registered an increase of 0.75% in short interest. SYBX’s total short interest was 1.08M shares in September as published by FINRA. Its up 0.75% from 1.07 million shares, reported previously. With 133,100 shares average volume, it will take short sellers 8 days to cover their SYBX’s short positions. The short interest to Synlogic Inc’s float is 7.56%.

The stock increased 3.50% or $0.48 during the last trading session, reaching $14.21. About 147,444 shares traded or 2.69% up from the average. Synlogic, Inc. (NASDAQ:SYBX) has declined 30.46% since September 30, 2017 and is downtrending. It has underperformed by 46.08% the S&P500.

Synlogic, Inc. develops synthetic biotic medicines for the treatment of patients with urea cycle disorder and phenylketonuria. The company has market cap of $361.37 million.

More news for Synlogic, Inc. (NASDAQ:SYBX) were recently published by: Seekingalpha.com, which released: “Synlogic reports positive Phase 1/2a data for SYNB1618 for the management of PKU” on September 04, 2018. Businesswire.com‘s article titled: “Synlogic to Webcast Presentation at the Leerink Partners Roundtable Series: Rare Disease & Oncology” and published on September 25, 2018 is yet another important article.

Synlogic, Inc. (NASDAQ:SYBX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: